Biolase, Inc. (BIOL) News
Filter BIOL News Items
BIOL News Results
|Loading, please wait...|
BIOL News Highlights
- BIOL's 30 day story count now stands at 6.
- Over the past 18 days, the trend for BIOL's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
Latest BIOL News From Around the Web
Below are the latest news stories about Biolase Inc that investors may wish to consider to help them evaluate BIOL as an investment opportunity.
BIOLASE and Healthy Smiles for Kids of Orange County (Healthy Smiles) Invite California Dental Community to Awareness Reception on Sept. 24
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and Healthy Smiles for Kids of Orange County (Healthy Smiles) are inviting dental professionals in the Orange County area to an awareness reception around the shared mission to improve the oral health of children in the community.
As the global economy recovers in fits and starts, one way to play the long-term expansion in global markets is with solid penny stocks.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021:
Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser adoption and increase hands-on training programs with one of the global leaders in endodontics.
Investing in penny stocks can be an intriguing numbers game.
Global Dental Veneers Market Report Forecast to 2021-2027 |key players are Colgate-Plmolive, Dentsply International, Zimmer, PHILIPS, DenMat, Ultradent Products, Lion, Henkel, Trident, Sirona Dental Systems, Align Technology, Biolase, Planmeca Oy, P&G, Un
Global Dental Veneers Market is driven by rising instances of dental embeds and expanding number of patients with corrective dentistry and rise dental the travel industry in developing business sector. Ascend in discretionary cashflow and expansion in speculations are probably
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider BIOLASE (BIOL).
Shares of Biolase Inc. (BIOL) are up about 22% since its consensus-beating Q2 results on August 12. Biolase’s dental laser systems enable various minimally invasive dental procedures. It also provides consumable products and accessories for its systems. Let’s take a look at the latest financial performance of the company and see what has changed in its key risk factors that investors should know. Biolase’s net Q2 revenue jumped 211% year-over-year to $9.1 million as more dental practices opened amid easing of pandemic restrictions, along with a robust addition of new customers in the U.S.
BIOLASE Expands Core Capabilities As It Appoints Three New Board Members With Significant Dental Experience
Demonstrating a deep commitment to expanding the core capabilities and diversity of its Board of Directors, BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has appointed three new board members to its Board of Directors (the "Board"), effective immediately. Drs. Kathleen T. O'Loughlin, Carol Gomez Summerhays, and Martha Somerman join a Board that has been instrumental in establishing and implementing the Company's business plan, which has demonstrated signifi
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...